Sartorius Stedim Biotech SA (SRTOY)
23.29
-0.99
(-4.08%)
USD |
OTCM |
Oct 08, 16:00
Sartorius Stedim Biotech Price to Book Value : 4.678 for Oct. 8, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 4.678 |
| October 07, 2026 | 4.877 |
| October 06, 2026 | 4.919 |
| October 05, 2026 | 4.821 |
| October 02, 2026 | 4.720 |
| October 01, 2026 | 4.766 |
| September 30, 2026 | 5.120 |
| September 29, 2026 | 5.011 |
| September 28, 2026 | 5.004 |
| September 25, 2026 | 4.864 |
| September 24, 2026 | 4.932 |
| September 23, 2026 | 4.71 |
| September 22, 2026 | 4.734 |
| September 21, 2026 | 4.636 |
| September 18, 2026 | 4.539 |
| September 17, 2026 | 4.495 |
| September 16, 2026 | 4.419 |
| September 15, 2026 | 4.413 |
| September 14, 2026 | 4.312 |
| September 11, 2026 | 4.336 |
| September 10, 2026 | 4.322 |
| September 09, 2026 | 4.515 |
| September 08, 2026 | 4.415 |
| September 04, 2026 | 4.415 |
| September 03, 2026 | 4.622 |
| Date | Value |
|---|---|
| September 02, 2026 | 4.582 |
| September 01, 2026 | 4.543 |
| August 31, 2026 | 4.592 |
| August 28, 2026 | 4.668 |
| August 27, 2026 | 4.604 |
| August 26, 2026 | 4.490 |
| August 25, 2026 | 4.569 |
| August 24, 2026 | 4.499 |
| August 21, 2026 | 4.546 |
| August 20, 2026 | 4.596 |
| August 19, 2026 | 4.282 |
| August 18, 2026 | 4.168 |
| August 17, 2026 | 4.100 |
| August 14, 2026 | 4.150 |
| August 13, 2026 | 4.221 |
| August 12, 2026 | 4.152 |
| August 11, 2026 | 4.140 |
| August 10, 2026 | 4.200 |
| August 07, 2026 | 4.096 |
| August 06, 2026 | 3.958 |
| August 05, 2026 | 3.97 |
| August 04, 2026 | 3.987 |
| August 03, 2026 | 3.816 |
| July 31, 2026 | 3.848 |
| July 30, 2026 | 3.898 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Lifecore Biomedical, Inc. | -- |
| Sanofi | 1.350 |
| Codexis, Inc. | 3.896 |
| Nicox SA | -- |
| Evotec SE | 0.7188 |
Price to Book Value Related Metrics
| PE Ratio | 66.41 |
| PS Ratio | 6.466 |
| PEG Ratio | 1.679 |
| Price to Free Cash Flow | 86.95 |
| Price | 23.29 |
| Earnings Yield | 1.51% |
| Market Cap | 22.66B |
| PEGY Ratio | 1.664 |
| Operating PE Ratio | 34.79 |
| Normalized PE Ratio | 56.89 |